NCT00966472 2020-04-21
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Ottawa Hospital Research Institute
Phase 1 Completed
Ottawa Hospital Research Institute
M.D. Anderson Cancer Center
Pfizer